AMP
69
-3
BIIB
26
2
MDLZ
34
2
MUR
43
3
CVX
46
5
OXY
40
3
ZTS
47
2
MPC
47
3
SYF
85
2
EOG
58
2
IBM
54
4
XOM
47
5
AXP
66
2
ADP
64
2
V
60
-6
TDC
75
4
PCG
93
2
HIG
67
4
PNW
66
3
NI
75
2
AMP
69
-3
BIIB
26
2
MDLZ
34
2
MUR
43
3
CVX
46
5
OXY
40
3
ZTS
47
2
MPC
47
3
SYF
85
2
EOG
58
2
IBM
54
4
XOM
47
5
AXP
66
2
ADP
64
2
V
60
-6
TDC
75
4
PCG
93
2
HIG
67
4
PNW
66
3
NI
75
2
Financhill
Back

Armata Pharmaceuticals 10K Form

Buy
51

ARMP
Armata Pharmaceuticals

Last Price:
2.10
Seasonality Move:
26.22%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ARMP News And Ratings

See the #1 stock for the next 7 days that we like better than ARMP

ARMP Financial Statistics

Sales & Book Value

Annual Sales: $820K
Cash Flow: $-9.2M
Price / Cash Flow: 0
Annual Sales: $-1.41
Price / Book: 0

Profitability

EPS (TTM): -1.64000
Net Income (TTM): $-41.36M
Gross Margin: $410K
Return on Equity: 0%
Return on Assets: 0%

Armata Pharmaceuticals Earnings Forecast

Key Armata Pharmaceuticals Financial Ratios

  • The Gross Profit Margin over the past 19 years for ARMP is 100.24%.
  • The Selling, General & Administrative Expenses for ARMP have been equal to 971.46% of Gross Profit Margin.
  • The Interest Expense is -3.80% of Operating Income.
  • Per Share Earnings over the last 28 years have been positive in 11 years.

Armata Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYAM
Industry: Biotechnology
Sector: Health Care
Current Symbol: ARMP
CUSIP: 04216R
Website: armatapharma.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

ARMP Technical Analysis vs Fundamental Analysis

Buy
51
Armata Pharmaceuticals (ARMP) is a Buy

Is Armata Pharmaceuticals a Buy or a Sell?